Patent · US Active

In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method

US11300569B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignees

ISERM (Institut National de la Santé et de la Recherche Médicale) · FR
UNIVERSITE DE PARIS DESCARTES · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR

Inventors

Jerome Galon · Paris, FR
Franck Pages · Paris, FR
Wolf Herman Fridman · Paris, FR

Key dates

Filing date	Dec 14, 2018
Grant date	Apr 12, 2022
Priority date	—
Expiry date	Nov 3, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.